NCT05840445View on ClinicalTrials.gov

Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

January 15, 2021

Study Completion Date

January 15, 2021

Conditions
FaceSkin FoldRejuvenation
Interventions
DRUG

Onabotulinum toxin A

Intramuscular application of onabotulinum toxin-A in the upper facial third.

DRUG

Prabotulinumtoxin A

Intramuscular application of prabotulinum toxin-A in the upper facial third.

Trial Locations (2)

06800

Institute of Ophthalmology, Conde de Valenciana Foundation, Mexico City

Instituto de Oftalmología, Mexico City

All Listed Sponsors
lead

Instituto de Oftalmología Fundación Conde de Valenciana

OTHER

NCT05840445 - Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles | Biotech Hunter | Biotech Hunter